We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
-27.48%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$68.1M
AUM Growth
-$40.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 73.44%
2 Communication Services 26.17%
3 Industrials 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
1
Tvardi Therapeutics
TVRD
$23.5M
$46.4M 68.07%
99,113
LVO icon
2
LiveOne
LVO
$66M
$17.8M 26.17%
360,294
MRSN
3
DELISTED
Mersana Therapeutics
MRSN
$3.25M 4.77%
31,858
SENS icon
4
Senseonics Holdings Inc
SENS
$254M
$413K 0.61%
7,980
FSNN
5
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$261K 0.38%
155,069

Similar funds

Rho Capital Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Rho Capital Partners held 5 positions worth $68.1M, down 37% from $109M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 87% a quarter earlier, followed by Communication Services and Industrials.

  • Rho Capital Partners's ten largest holdings make up 100% of its $68.1M portfolio in Q4 2018.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q4 2018.
  • Rho Capital Partners's portfolio value fell 37% quarter-over-quarter to $68.1M.

Based on Rho Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.